IGAM
ALNY icon

iA Global Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

iA Global Asset Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.33M Buy
17,693
+1,771
+11% +$534K 0.06% 203
2026
Q1 		$5.27M Sell
15,922
-1,858
-10% -$632K 0.07% 189
2025
Q4 		$7.07M Buy
17,780
+16,133
+980% +$7.14M 0.09% 164
2025
Q3 		$751K Buy
+1,647
New +$671K 0.01% 317

Other funds holding ALNY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

iA Global Asset Management's ALNY Position: Q2 2026 in Review

iA Global Asset Management increased its Alnylam Pharmaceuticals (ALNY) stake by 11% in Q2 2026, buying an estimated $534K and bringing the position to 17,693 shares worth $5.33M. The position accounts for 0.06% of the portfolio, ranked #203.

iA Global Asset Management first reported a position in ALNY in Q3 2025 and has held it in 4 quarters since. The position peaked at $7.07M in Q4 2025. 365 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • iA Global Asset Management held 17,693 shares of Alnylam Pharmaceuticals worth $5.33M as of Q2 2026.
  • iA Global Asset Management bought 1,771 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $534K.
  • Alnylam Pharmaceuticals made up 0.06% of iA Global Asset Management's portfolio in Q2 2026, its #203 holding.
  • iA Global Asset Management first reported a position in Alnylam Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • iA Global Asset Management's Alnylam Pharmaceuticals position peaked at $7.07M in Q4 2025.
  • 365 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on iA Global Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.